Cyprodenate

This classification denotes a cns stimulant with the molecular formula C13H25NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I44VIC13P8, chemically known as cyclohexanepropionic acid, 2-(dimethylamino)ethyl ester but generally known as cyprodenate, which bears US NIH Compound Identifier 71875. European Medicines Agency schedules Cyprodenate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06874MIG. The term CYPRODENATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). CYPRODENATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cyprodenate under HS 29221980 and SITC 51461. As of Q4 2014, CYPRODENATE remains the US FDA Preferred Term for this commodity. Cyprodenate bears US NLM identifiers UMLS ID C0056852 and NCI Concept Code C76619. SMILES: O(C(=O)CCC1CCCCC1)CCN(C)C.